Literature DB >> 20171548

Pneumocystis jirovecii Pneumonia.

Emilie Catherinot1, Fanny Lanternier, Marie-Elisabeth Bougnoux, Marc Lecuit, Louis-Jean Couderc, Olivier Lortholary.   

Abstract

Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus on the evolving pathophysiology and epidemiology. Pneumocystis pneumonia still remains a severe opportunistic infection, associated with a high mortality rate. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171548     DOI: 10.1016/j.idc.2009.10.010

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  54 in total

1.  Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.

Authors:  Milène Sasso; Elsa Chastang-Dumas; Sophie Bastide; Sandrine Alonso; Catherine Lechiche; Nathalie Bourgeois; Laurence Lachaud
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

2.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

3.  Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.

Authors:  Aleem Gangjee; Ojas A Namjoshi; Sudhir Raghavan; Sherry F Queener; Roy L Kisliuk; Vivian Cody
Journal:  J Med Chem       Date:  2013-05-21       Impact factor: 7.446

4.  Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.

Authors:  Kota Shimada; Kyoko Yokosuka; Takahiro Nunokawa; Shoji Sugii
Journal:  Clin Rheumatol       Date:  2018-06-06       Impact factor: 2.980

Review 5.  Pathological and protective immunity to Pneumocystis infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

Review 6.  Advances in the diagnosis of fungal pneumonias.

Authors:  Bryan T Kelly; Kelly M Pennington; Andrew H Limper
Journal:  Expert Rev Respir Med       Date:  2020-04-21       Impact factor: 3.772

Review 7.  Fungal infections of the lung in children.

Authors:  Paolo Toma; Alice Bertaina; Elio Castagnola; Giovanna Stefania Colafati; Maria Luisa D'Andrea; Andrea Finocchi; Vincenzina Lucidi; Angela Mastronuzzi; Claudio Granata
Journal:  Pediatr Radiol       Date:  2016-09-23

Review 8.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

9.  Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans.

Authors:  Bava Javier; Lloveras Susana; Garro Santiago; Troncoso Alcides
Journal:  Asian Pac J Trop Biomed       Date:  2012-01

Review 10.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.